article thumbnail

Gene editing: beyond the hype

pharmaphorum

Genome editing is an exciting but still nascent field, and companies in the area face as many obstacles as they do opportunities. Then over the next two or three years, gene therapy was accepted as something that companies got involved in, and several biotechs have been bought up by big pharma.”. The genomic medicine journey.

article thumbnail

Genetic biomarkers could personalise therapy for TNBC

Drug Discovery World

The authors therefore recommend against doctors routinely using biopsies taken from primary tumour samples to carry out gene-expression (RNA)-based biomarker tests for guiding the treatment for secondary cancers.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

What to expect from SLAS Europe 2023

Drug Discovery World

SLAS Student Poster Award The SLAS Student Poster Award recognises innovative research by students, graduate students, post- doctoral associates and junior faculty (less than four years in first academic appointment) who are chosen to present a poster during SLAS Europe 2023. It will be led by Björn C.

Doctors 52
article thumbnail

Women in Science Who Have Paved the Way Forward in Genetics

XTalks

The Human Genome Project recently marked 20 years since the publication of the first full sets of human genomic sequences, an endeavor that spanned well over a decade. Today, new next-generation sequencing technologies allow for the sequencing of complex genomes within just a day or two.

Genetics 119
article thumbnail

FAIR Game: making data work harder in the race to market 

Drug Discovery World

For example, GEO, the gene expression omnibus database, has been collecting gene expression and functional genomics datasets and making them available to the public for more than 20 years. Many efforts have been made to standardise certain types of results. Volume 23 – Issue 4, Fall 2022 . Reference: .